UB Paderborn / Katalog / Suche / in CDI

Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

Breast (Edinburgh), 2021-12, Vol.60, p.131-137

2021

Volltextzugriff (PDF)

Results of pancreaticoduodenectomy for pancreatic cancer: Extended versus standard procedure

World journal of surgery, 2002-11, Vol.26 (11), p.1309-1314

2002

Volltextzugriff (PDF)

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis

Therapeutic advances in medical oncology, 2023-01, Vol.15, p.17588359231193732-17588359231193732

2023

Volltextzugriff (PDF)

Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB111:01, and HLA-DQB103:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report

Journal of medical case reports, 2016-09, Vol.10 (1), p.254-254, Article 254

2016

Volltextzugriff (PDF)

Lactobacillus plantarum Reduces Infection of Pancreatic Necrosis in Experimental Acute Pancreatitis

Digestive surgery, 2001, Vol.18 (1), p.47-50

2001

Volltextzugriff (PDF)

Incidental gallbladder carcinoma

Chirurgia italiana, 2007-03, Vol.59 (2), p.185

2007

Volltextzugriff (PDF)

Abdominal incisional hernia repair. Intraperitoneal prosthetic technique using Bard Kugel Composix Mesh

Chirurgia italiana, 2007-09, Vol.59 (5), p.735

2007

Volltextzugriff (PDF)

Multimodality Therapy of Rectal Cancer

Rectal Cancer, p.203-213

Volltextzugriff (PDF)

Surgical treatment of breast tumors in patients after mammography screening. Personal experience in the first 3 years of operation of the screening program in the province of Verona

Chirurgia italiana, 2003-05, Vol.55 (3), p.351

2003

Volltextzugriff (PDF)

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

The New England journal of medicine, 2020-12, Vol.383 (23), p.2207-2218

2020

Volltextzugriff (PDF)

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

The lancet oncology, 2022-05, Vol.23 (5), p.659-670

2022

Volltextzugriff (PDF)

Complications of Early Versus Delayed Total Elbow Arthroplasty for the Treatment of Distal Humerus Fractures

The Journal of hand surgery (American ed.), 2024-07, Vol.49 (7), p.707.e1-707.e7

2024

Volltextzugriff (PDF)

Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7

Nature structural & molecular biology, 2014-11, Vol.21 (11), p.955

2014

Volltextzugriff (PDF)

The Effect of Joint Hypermobility Syndrome on DOMS and Recovery Time

International journal of sports physical therapy, 2024-02, Vol.19 (2), p.159-165

2024

Volltextzugriff (PDF)

Long-term results of implants treated with guided bone regeneration: a 5-year prospective study

The International journal of oral and maxillofacial implants, 2001-05, Vol.16 (3), p.355

2001

Volltextzugriff (PDF)

Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study

Journal of clinical oncology, 2020-06, Vol.38 (18_suppl), p.LBA4-LBA4

2020

Volltextzugriff (PDF)

Assessing the Feasibility of Using Sentinel-2 Imagery to Quantify the Impact of Heatwaves on Irrigated Vineyards

Remote sensing (Basel, Switzerland), 2019-12, Vol.11 (23), p.2869

2019

Volltextzugriff (PDF)

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

Leukemia, 2022-03, Vol.36 (3), p.772-780

2022

Volltextzugriff (PDF)

Favezelimab (anti–LAG-3) plus pembrolizumab in patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after anti–PD-1 treatment: An open-label phase 1/2 study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7545-7545

2022

Volltextzugriff (PDF)

Favezelimab (anti–LAG-3) plus pembrolizumab in patients with anti–PD-1–naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An open-label phase 1/2 study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.7516-7516

2022

Volltextzugriff (PDF)

O7-3 Pembrolizumab vs chemotherapy in MSI-H / dMMR metastatic colorectal cancer: KEYNOTE-177 final analysis Asia subgroup

Annals of oncology, 2022-07, Vol.33, p.S471

2022

Volltextzugriff (PDF)

Early Clinical Failure of a Cementless Thumb Basal Joint Hemiarthroplasty for the Treatment of Trapeziometacarpal Osteoarthritis

The Journal of hand surgery (American ed.), 2016-09, Vol.41 (9), p.S12-S13

2016

Volltextzugriff (PDF)

Early Clinical Failure of a Cementless Thumb Basal Joint Hemiarthroplasty for the Treatment of Trapeziometacarpal Osteoarthritis: Level 4 Evidence

The Journal of hand surgery (American ed.), 2016-09, Vol.41 (9), p.S12-S13

2016

Volltextzugriff (PDF)

P1065: UPDATED RESULTS FROM AN OPEN‐LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD‐1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e0274602-n/a

2023

Volltextzugriff (PDF)

P1068: UPDATED RESULTS FROM AN OPEN‐LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER ANTI–PD‐1 TREATMENT

HemaSphere, 2023-08, Vol.7 (S3), p.e5990067-n/a

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

Results of pancreaticoduodenectomy for pancreatic cancer: Extended versus standard procedure

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis

Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB111:01, and HLA-DQB103:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report

Lactobacillus plantarum Reduces Infection of Pancreatic Necrosis in Experimental Acute Pancreatitis

Incidental gallbladder carcinoma

Abdominal incisional hernia repair. Intraperitoneal prosthetic technique using Bard Kugel Composix Mesh

Multimodality Therapy of Rectal Cancer

Surgical treatment of breast tumors in patients after mammography screening. Personal experience in the first 3 years of operation of the screening program in the province of Verona

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

Complications of Early Versus Delayed Total Elbow Arthroplasty for the Treatment of Distal Humerus Fractures

Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7

The Effect of Joint Hypermobility Syndrome on DOMS and Recovery Time

Long-term results of implants treated with guided bone regeneration: a 5-year prospective study

Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study

Assessing the Feasibility of Using Sentinel-2 Imagery to Quantify the Impact of Heatwaves on Irrigated Vineyards

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

Favezelimab (anti–LAG-3) plus pembrolizumab in patients with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) after anti–PD-1 treatment: An open-label phase 1/2 study

Favezelimab (anti–LAG-3) plus pembrolizumab in patients with anti–PD-1–naive relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL): An open-label phase 1/2 study

O7-3 Pembrolizumab vs chemotherapy in MSI-H / dMMR metastatic colorectal cancer: KEYNOTE-177 final analysis Asia subgroup

Early Clinical Failure of a Cementless Thumb Basal Joint Hemiarthroplasty for the Treatment of Trapeziometacarpal Osteoarthritis

Early Clinical Failure of a Cementless Thumb Basal Joint Hemiarthroplasty for the Treatment of Trapeziometacarpal Osteoarthritis: Level 4 Evidence

P1065: UPDATED RESULTS FROM AN OPEN‐LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD‐1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA

P1068: UPDATED RESULTS FROM AN OPEN‐LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER ANTI–PD‐1 TREATMENT

Suchergebnisse filtern